You just read:

Symbiomix Therapeutics Accelerates Commercial Launch Preparation for Solosec™ Following Presentation of Results from Second Pivotal Trial at IDSOG

News provided by

Symbiomix Therapeutics, LLC

17 Aug, 2016, 08:00 ET